Ketoconazole Foam 2% for the Treatment of Versicolor
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
Ten adult patients age 19 and older with a clinical diagnosis of tinea versicolor, as well as
a positive Potassium Hydroxide (KOH) using calcofluor. Ketoconazole 2% foam will be used to
determine its effectiveness, safety and satisfaction when used to treat tinea versicolor.